A partnership between Northeastern's Roux Institute and Techstars delivers a startup accelerator program in Portland and potential D'Amore-McKim credits for Techstars alumni.
Friends, including a D'Amore-McKim colleague, celebrate the 50-year-long tenure of Linda Allen, Northeastern's retiring associate vice president and university registrar.
Rachel Domb, COS'24, saw a gap in eco-friendly packaging for snacks. Cue her plant-based food venture, Rooted Living.
As the U.S. Securities and Exchange Commission investigates the GameStop market phenomenon, day traders are on to the next target.
The launch of the Center for Emerging Markets Vivek and Vandana Sharma India Initiative will create a groundbreaking package of programs that will expand and deepen the school's engagement with economic and business issues in India.
Super Bowl LV advertisers adopt nostalgic messaging after a year of chaos.
The D'Amore-McKim community welcomes four new Board of Visitors members to help shape its strategic goals.
D'Amore-McKim researchers explain how a group of Reddit investors drove up the falling value of GameStop's stock.
“Northeastern MBA residents are always prepared and professional—they speak the right language. They're self-starters; I can trust that if I give them an assignment, they're going to go figure it out.” – Bill Forbes, Senior Director of Global Supply Chain at Raytheon
“When you hire externally, there's always a risk. But with Northeastern residents, we already know the quality of their work and the caliber of their education. We've challenged them, pressure-tested them, and given them tough assignments over six months on corporate residency, and found out where their strengths and weaknesses are. It just makes so much sense to hire them, and it makes for a smooth transition.” – Bill Forbes, Senior Director of Global Supply Chain at Raytheon
Mohamed Bennis, DMSB'21, is taking over our Instagram @damoremckim this week! Follow along for an inside look at his experience at D'Amore-McKim including co-ops, clubs, and more!
The U.S. must take a centralized approach to the COVID-19 vaccine supply chain says Professor Nada Sanders.